BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38418452)

  • 21. RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures.
    Mendler JH; Maharry K; Radmacher MD; Mrózek K; Becker H; Metzeler KH; Schwind S; Whitman SP; Khalife J; Kohlschmidt J; Nicolet D; Powell BL; Carter TH; Wetzler M; Moore JO; Kolitz JE; Baer MR; Carroll AJ; Larson RA; Caligiuri MA; Marcucci G; Bloomfield CD
    J Clin Oncol; 2012 Sep; 30(25):3109-18. PubMed ID: 22753902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-363-3p promote the development of acute myeloid leukemia with RUNX1 mutation by targeting SPRYD4 and FNDC3B.
    Chen Y; Chen S; Lu J; Yuan D; He L; Qin P; Tan H; Xu L
    Medicine (Baltimore); 2021 May; 100(18):e25807. PubMed ID: 33950983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias.
    Rocquain J; Carbuccia N; Trouplin V; Raynaud S; Murati A; Nezri M; Tadrist Z; Olschwang S; Vey N; Birnbaum D; Gelsi-Boyer V; Mozziconacci MJ
    BMC Cancer; 2010 Aug; 10():401. PubMed ID: 20678218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic Mutation Profiles of Patients with Acute Myeloid Leukemia in Korea: a Single-Center Experience.
    Han E; Ryu S; Kim D; Koh EH; Byun JH; Lee DH
    Clin Lab; 2023 Nov; 69(11):. PubMed ID: 37948498
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Kurzer JH; Weinberg OK
    Front Oncol; 2021; 11():704471. PubMed ID: 34381727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancer recruitment of transcription repressors RUNX1 and TLE3 by mis-expressed FOXC1 blocks differentiation in acute myeloid leukemia.
    Simeoni F; Romero-Camarero I; Camera F; Amaral FMR; Sinclair OJ; Papachristou EK; Spencer GJ; Lie-A-Ling M; Lacaud G; Wiseman DH; Carroll JS; Somervaille TCP
    Cell Rep; 2021 Sep; 36(12):109725. PubMed ID: 34551306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myeloid neoplasms with t(16;21)(q24;q22)/RUNX1-RUNX1T3 mimics acute myeloid leukemia with RUNX1-RUNX1T1.
    Liu H; Wang SA; Schlette EJ; Xu J; Jorgensen JL; Cameron Yin C; Li S; Jeffrey Medeiros L; Tang G
    Ann Hematol; 2018 Oct; 97(10):1775-1783. PubMed ID: 29872884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PHF6 maintains acute myeloid leukemia via regulating NF-κB signaling pathway.
    Hou S; Wang X; Guo T; Lan Y; Yuan S; Yang S; Zhao F; Fang A; Liu N; Yang W; Chu Y; Jiang E; Cheng T; Sun X; Yuan W
    Leukemia; 2023 Aug; 37(8):1626-1637. PubMed ID: 37393343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PHF6 mutation is associated with poor outcome in acute myeloid leukaemia.
    Huang K; Wang L; Zheng Y; Yue C; Xu X; Chen H; Huang R; Li Y
    Cancer Med; 2023 Feb; 12(3):2795-2804. PubMed ID: 36176187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinico-pathologic characteristics and outcomes of the World Health Organization (WHO) provisional entity de novo acute myeloid leukemia with mutated RUNX1.
    Quesada AE; Montalban-Bravo G; Luthra R; Patel KP; Sasaki K; Bueso-Ramos CE; Khoury JD; Routbort MJ; Bassett R; Hidalgo-Lopez JE; Zhao C; Lin P; Loghavi S; Ok CY; Kadia T; DiNardo CD; Kantarjian H; Garcia-Manero G; Kanagal-Shamanna R
    Mod Pathol; 2020 Sep; 33(9):1678-1689. PubMed ID: 32238878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RUNX1 and CBFβ Mutations and Activities of Their Wild-Type Alleles in AML.
    Hyde RK; Liu P; Friedman AD
    Adv Exp Med Biol; 2017; 962():265-282. PubMed ID: 28299663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ASXL genes and RUNX1: an intimate connection?
    Metzeler KH
    Blood; 2014 Aug; 124(9):1382-3. PubMed ID: 25170110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical characteristics and prognostic study of adult acute myeloid leukemia patients with
    Lin Y; Wang Y; Zheng Y; Wang Z; Wang Y; Wang S
    Hematology; 2020 Dec; 25(1):446-456. PubMed ID: 33250015
    [No Abstract]   [Full Text] [Related]  

  • 34. Identification of Key Genes and Pathways Associated with RUNX1 Mutations in Acute Myeloid Leukemia Using Bioinformatics Analysis.
    Zhu F; Huang R; Li J; Liao X; Huang Y; Lai Y
    Med Sci Monit; 2018 Oct; 24():7100-7108. PubMed ID: 30289875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations of PHF6 are associated with mutations of NOTCH1, JAK1 and rearrangement of SET-NUP214 in T-cell acute lymphoblastic leukemia.
    Wang Q; Qiu H; Jiang H; Wu L; Dong S; Pan J; Wang W; Ping N; Xia J; Sun A; Wu D; Xue Y; Drexler HG; Macleod RA; Chen S
    Haematologica; 2011 Dec; 96(12):1808-14. PubMed ID: 21880637
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Xiao W; Bharadwaj M; Levine M; Farnhoud N; Pastore F; Getta BM; Hultquist A; Famulare C; Medina JS; Patel MA; Gao Q; Lewis N; Pichardo J; Baik J; Shaffer B; Giralt S; Rampal R; Devlin S; Cimera R; Zhang Y; E Arcila M; Papaemmanuil E; Levine RL; Roshal M
    Blood Adv; 2018 Dec; 2(23):3526-3539. PubMed ID: 30530780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDS.
    Inoue D; Kitaura J; Matsui H; Hou HA; Chou WC; Nagamachi A; Kawabata KC; Togami K; Nagase R; Horikawa S; Saika M; Micol JB; Hayashi Y; Harada Y; Harada H; Inaba T; Tien HF; Abdel-Wahab O; Kitamura T
    Leukemia; 2015 Apr; 29(4):847-57. PubMed ID: 25306901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural and functional insights into the human Börjeson-Forssman-Lehmann syndrome-associated protein PHF6.
    Liu Z; Li F; Ruan K; Zhang J; Mei Y; Wu J; Shi Y
    J Biol Chem; 2014 Apr; 289(14):10069-83. PubMed ID: 24554700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concurrent Mutations in
    Zuo Z; Medeiros LJ; Garces S; Routbort MJ; Ok CY; Loghavi S; Kanagal-Shamanna R; Jelloul FZ; Garcia-Manero G; Chien KS; Patel KP; Luthra R; Yin CC
    Biology (Basel); 2022 Dec; 12(1):. PubMed ID: 36671709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia.
    Fischer J; Rossetti S; Datta A; Eng K; Beghini A; Sacchi N
    Mol Cancer; 2015 Jan; 14():7. PubMed ID: 25612891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.